Berberine vs Semaglutide for weight loss
Short answer: For weight loss, users rate them about the same: 83% report improvement with Berberine (24 reports) and 85% with Semaglutide (138 reports).
Berberine has 109 meta-analyses and 110 randomized trials on PubMed; Semaglutide has 421 and 307.
Based on 373 reports about Berberine and 330 about Semaglutide. Not medical advice.
| Berberine Supplement | Semaglutide Medication | |
|---|---|---|
| Users say it helped | 56%helped119 reports · high confidence | 64%helped228 reports · high confidence |
| Verdict | Mixed | Mostly positive |
| Research | AResearch: Strong | AResearch: Strong |
| Meta-analyses / RCTs | 109 / 110 | 421 / 307 |
| Mainly used for | ||
| Weight loss % reporting improvement | 83% (24) | 85% (138) |
| Blood sugar % reporting improvement | 87% (82) | 90% (10) |
| Appetite % reporting improvement | 84% (19) | 80% (70) |
| Energy % reporting improvement | 91% (23) | 39% (23) |
| Mood % reporting improvement | 87% (15) | 27% (11) |
| Common side effects | stomach issues, constipation, anxiety, brain fog | nausea, fatigue, stomach issues, constipation |
| Typical dose reported | 400-500 mg / daily | Not listed |
Treatment with berberine may be safe since it does not increase the incidence of total adverse events and the risk of hypoglycemia. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=292975, identifier CRD42021292975.
Front Pharmacol, 2022 ↗“I started berberine and inositol, and began having energy that I did not have before. Somehow, my recovery after working out wasn't as long either.”
This study shows that new anti-diabetic drugs, particularly GLP1-RA and Tirzepatide, are the most effective in inducing weight loss in patients with type 2 diabetes. Interestingly, exenatide appears to be the only GLP1-RA that induces a mild weight loss.
Pharmacol Res, 2021 ↗“I've lost 35lbs since then and now I'm in the Healthy range on BMI. My IBSD has virtually disappeared.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate